Two-Colour Fluorescence Marker for Neurodegenerative Diseases
Worldwide it is estimated that there are 29 million cases of Alzheimer Disease (AD) and about 4 million of Parkinson's Disease (PD). The world market for AD and PD is estimated to be 14 billion dollars corresponding to an annual growth rate of 20%, making it an very attractive field for R&D to generate novel therapeuticals. Recently, the accumulation of dysfunctional mitochondria has been linked to neurodegenerative diseases, in particular to AD and PD. Scientists at the University of Göttingen have developed a powerful fluorescent marker for Live Cell Imaging to study mitochondrial dysfunctions and for testing novel pharmaceutical products
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Scientists transform blood into regenerative materials
… paving the way for personalized, blood-based, 3D-printed implants. Scientists have created a new ‘biocooperative’ material based on blood, which has shown to successfully repair bones, paving the way for…
A new experimental infection model in flies
…offers a fast and cost-effective way to test drugs. Researchers at the Germans Trias i Pujol Research Institute and Hospital have reinforced their leading role in infectious disease research by…
Material developed with novel stretching properties
KIT researchers produce metamaterial with different extension and compression properties than conventional materials. With this material, the working group headed by Professor Martin Wegener at KIT’s Institute of Applied Physics…